Scientific Research and Essays

  • Abbreviation: Sci. Res. Essays
  • Language: English
  • ISSN: 1992-2248
  • DOI: 10.5897/SRE
  • Start Year: 2006
  • Published Articles: 2753

Full Length Research Paper

Development and execution of a novel strategic statistical tool to determine in-vitro in-vivo correlation for sustained release capsules of metoprolol tartrate in humans

Sabahuddin Siddique
  • Sabahuddin Siddique
  • Patel College of Pharmacy, Madhyanchal Professional University, Bhopal, M. P., India.
  • Google Scholar
Mohi Iqbal Mohammed Abdul
  • Mohi Iqbal Mohammed Abdul
  • College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
  • Google Scholar
Syed Ata Ur Rahman
  • Syed Ata Ur Rahman
  • College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
  • Google Scholar
Durdana Lateef
  • Durdana Lateef
  • College of Science, Taibah University, Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
  • Google Scholar
Anirbandeep Bose
  • Anirbandeep Bose
  • TAAB Biostudy Services, Jadavpur, Kolkata, India
  • Google Scholar
Shubhasis Dan
  • Shubhasis Dan
  • TAAB Biostudy Services, Jadavpur, Kolkata, India
  • Google Scholar
Faraz Siddiqui
  • Faraz Siddiqui
  • Sun Pharmaceutical Industries Limited, Halol, Gujrat, India.
  • Google Scholar


  •  Received: 06 November 2018
  •  Accepted: 30 November 2018
  •  Published: 15 January 2019

References

Aqil M, Ahad A, Sultana Y, Najmi AK, Saha NA (2007). validated HPLC method for estimation of metoprolol in human plasma. Acta Chromatographica 19:130-140.

 

Center for Drug Evaluation and Research (CDER) (1997). Extended release solid oral dosage forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations; USA. US Department of Health &Human services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER).

 

Food and Drug Administration (FDA) (2017). Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system, CDER (2000). Food and Drug Administration, US Department of Health and Human services, Center for Drug Evaluation and Research (CDER). 

View

 

Gibaldi M, Perrier D, Marcel D (1982). Pharmacokinetics New York, (2nd edn, revised and expanded). Mandal U, Ray KK, Gowda V, Ghosh A, Pal TK (2007). In-vitro and in-vivo correlation for two gliclazide extended-release tablets. Journal of Pharmacognosy and Pharmacology 59(7):971-976.

 

Grbic S, Parojcic J, Ibric S, Djuric Z (2011). In vitro-in vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation. Aaps Pharmscitech 12(1):165-171.
Crossref

 

Henry F, Moore JW (1996). Mathematical comparison of curves with an emphasis on dissolution profiles. Pharmaceutical Technology 20:64-74.

 

Jerome PS, Gordon LA, William HB, Leslie ZB, James EC, Joseph RR, Vinod PS, Avrahma Y, Jean MA, Kenneth SA (1990). Report of the workshop on in vitro and in vivo testing and correlation for oral controlled/modified-release dosage forms. Journal of Pharmaceutical Science 79:849-854.
Crossref

 

Russell JR (1997). Examples of in vitro-in vivo relationships with a diverse range of quality. Biopharmaceutics. Purepac pharmaceutical co., a subsidiary of Faulding, Inc. New Jersey 07207.

 

Sabahuddin S, Jasmina K, Papiya B (2010). Development of sustained release capsules containing "coated matrix granules of metoprolol tartrate". Aaps Pharmscitech 11(9):1306-1314.

 

USP Subcommittee on Biopharmaceutics (1988). In-vitro-in vivo correlation for extended release oral dosage forms. Pharm. Forum, USA, July–Aug: 4160-4161. 

View

 

Ziad H, Michael F (1990). Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation. Pharmaceutical Research 7(11):1167-1171.
Crossref